Fludeoxyglucose F 18 Injection
Product Images NDC 67939-010

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Fludeoxyglucose F 18 (NDC 67939-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by The University Of Utah Dba Cyclotron Radiochemistry Lab / Huntsman Cancer Institute, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure

Chemical structure of Fludeoxyglucose F 18, showing its molecular arrangement with labeled oxygen, hydrogen, carbon atoms and the radioactive fluorine isotope F-18.*

FDA Label Image

Draft Fludeoxyglucose F 18 Injection 35ml Outer Packaging

Label for Fludeoxyglucose F 18 Injection, USP, a sterile, non-pyrogenic intravenous injection with activity ranging from 20 mCi/mL to 300 mCi/mL. The label includes information on calibration, storage at 25°C, radioactive material caution, and details that it is manufactured by The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute.*

FDA Label Image

Draft Fludeoxyglucose F 18 Injection 35ml Vial Packaging

Drug facts text panel for Fludeoxyglucose F 18 Injection, USP, a multiple-dose vial with activity ranging from 20 mCi/mL to 300 mCi/mL at End of Synthesis (EOS). Includes instructions for calibration, storage at 25°C, radioactive material caution, and manufacturer details: The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute, Salt Lake City, UT. For intravenous use only with specified handling guidelines.*

FDA Label Image

Draft Fludeoxyglucose F 18 Injection 50ml Outer Packaging

Drug Facts panel for Fludeoxyglucose F 18 Injection, USP showing concentration from 20 mCi/mL to 300 mCi/mL. It lists sterile, non-pyrogenic status, calibration details, radioactive content with sodium chloride in citrate buffer, and storage instructions at 25°C. The label warns radioactive material caution and provides manufacturer details for The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute.*

FDA Label Image

Draft Fludeoxyglucose F 18 Injection 50ml Vial Packaging

Fludeoxyglucose F 18 Injection, USP, multiple-dose vial label showing a concentration range of 20 mCi/mL to 300 mCi/mL. The label includes instructions for intravenous use, storage conditions, radioactive material caution, and manufacturing information by The University of Utah DBA Cyclotron Radiochemistry Lab / Huntsman Cancer Institute. It specifies that the product is sterile, non-pyrogenic, and contains Fludeoxyglucose F 18 with sodium chloride in citrate buffer.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.